Online first
Research paper
Published online: 2025-03-26

open access

Page views 59
Article views/downloads 39
Get Citation

Connect on Social Media

Connect on Social Media

The prevalence of Group B Streptococcus rectovaginal colonization and antimicrobial susceptibility pattern in Turkish and Syrian pregnant women

Emine Kirtis1, Burak Karadag1, Aysel Uysal1, Yeşim Çekin2, Gul Alkan Bulbul1

Abstract

Objectives: Colonization with Group B Streptococcus (GBS) during pregnancy can lead to invasive GBS disease (iGBS) in neonates, including meningitis, pneumonia or sepsis, which carries a high mortality risk. American College of Obstetricians and Gynecologists (ACOG) recommends universal GBS screening for all pregnant individuals between 36 0/7 and 37 6/7 weeks of gestation. However, due to the insufficient population-based studies on universal screening and GBS colonization rates in late periods of pregnancy in Türkiye, we aimed to evaluate the prevalence of GBS and its antibiotic resistance to enhance awareness regarding GBS screening and prophylaxis during pregnancy and promote the use of appropriate antibiotics.

Material and methods: This prospective, single-center study was conducted between May 2017 and December 2017 on 518 pregnant women (363 Turkish and 155 Syrian). Vaginal and rectal samples were collected and cultured in Todd–Hewitt broth. Standard microbiological protocols were used to assess GBS colonization and antibiotic susceptibility.

Results: In the study, we found that 10.6% (n = 55) of pregnant women were colonized with GBS asymptomatically. Group B Streptococcus colonization rates did not differ significantly between Turkish patients (11%, n = 40) and Syrian patients (9.7%, n = 15) (p = 0.756, p > 0.05). All patients colonized with GBS were penicillin-sensitive. However, resistance to at least one non-penicillin antibiotic was observed in 42.5% (n = 17) of Turkish patients and 60% (n = 9) of Syrian patients. Although not statistically significant (p > 0.05), Syrian patients exhibited relatively higher rates of antibiotic resistance, especially to erythrosine and clindamycin.

Conclusions: In our country, implementing universal screening for asymptomatic GBS in pregnant women, as recommended by the Centers for Disease Control and Prevention (CDC), would be more beneficial than a risk-based screening approach. Given the increased resistance patterns observed in antibiogram results, GBS prophylaxis at delivery, especially in patients with penicillin allergies, should be planned based on antibiotic susceptibility testing.

Article available in PDF format

View PDF Download PDF file

References

  1. Alotaibi NM, Alroqi S, Alharbi A, et al. Clinical characteristics and treatment strategies for Group B Streptococcus (GBS) infection in pediatrics: a systematic review. Medicina (Kaunas). 2023; 59(7).
  2. Bernardini R, Aufieri R, Detcheva A, et al. Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model. J Matern Fetal Neonatal Med. 2017; 30(23): 2844–2850.
  3. Kwatra G, Cunnington MC, Merrall E, et al. Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016; 16(9): 1076–1084.
  4. Lamont RF, Jørgensen JS, Vinter CA. Re: Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis. BJOG. 2020; 127(9): 1167–1168.
  5. Kumalo A, Gebre B, Shiferaw S, et al. recto-vaginal colonization, antimicrobial susceptibility pattern, and associated factors among pregnant women at selected health facilities of Wolaita Sodo Town, Southern Ethiopia. Front Microbiol. 2023; 14: 1277928.
  6. Gizachew M, Tiruneh M, Moges F, et al. Proportion of Streptococcus agalactiae vertical transmission and associated risk factors among Ethiopian mother-newborn dyads, Northwest Ethiopia. Sci Rep. 2020; 10(1): 3477.
  7. Afonso ED, Blot S. Effect of gestational age on the epidemiology of late-onset sepsis in neonatal intensive care units - a review. Expert Rev Anti Infect Ther. 2017; 15(10): 917–924.
  8. Hu S, Zhong H, Huang W, et al. Rapid and visual detection of Group B streptococcus using recombinase polymerase amplification combined with lateral flow strips. Diagn Microbiol Infect Dis. 2019; 93(1): 9–13.
  9. Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group b streptococcal disease in the united states, 2006 to 2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019; 173(3): 224–233.
  10. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002; 51(RR-11): 1–22.
  11. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782. Obstet Gynecol. 2019; 134(1): 1.
  12. Leclercq R, Cantón R, Brown DFJ, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013; 19(2): 141–160.
  13. Akkaneesermsaeng W, Petpichetchian C, Yingkachorn M, et al. Prevalence and risk factors of group B colonisation in intrapartum women: a cross-sectional study. J Obstet Gynaecol. 2019; 39(8): 1093–1097.
  14. Rao GG, Hiles S, Bassett P, et al. Differential rates of group B streptococcus (GBS) colonisation in pregnant women in a racially diverse area of London, UK: a cross‐sectional study. BJOG: An International Journal of Obstetrics & Gynaecology. 2019; 126(11): 1347–1353.
  15. Alp F, Findik D, Dagi HT, et al. Screening and genotyping of group B streptococcus in pregnant and non-pregnant women in Turkey. J Infect Dev Ctries. 2016; 10(3): 222–226.
  16. Kadanali A, Altoparlak U, Kadanali S. Maternal carriage and neonatal colonisation of group B streptococcus in eastern Turkey: prevalence, risk factors and antimicrobial resistance. Int J Clin Pract. 2005; 59(4): 437–440.
  17. Yücesoy G, Calişkan E, Karadenizli A, et al. Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis. Int J Clin Pract. 2004; 58(8): 735–739.
  18. Ayata A, Güvenç H, Felek S, et al. Maternal carriage and neonatal colonisation of group B streptococci in labour are uncommon in Turkey. Paediatr Perinat Epidemiol. 1994; 8(2): 188–192.
  19. Darabi R, Tadi S, Mohit M, et al. The prevalence and risk factors of group B streptococcus colonization in Iranian pregnant women. Electron Physician. 2017; 9(5): 4399–4404.
  20. Rabaan AA, Saunar JV, Bazzi AM, et al. Modified use of real-time PCR detection of group B Streptococcus in pregnancy. J Med Microbiol. 2017; 66(10): 1516–1520.
  21. Yan JJ, Gong M, Zhang J, et al. The relationship between group B streptococcus genital infection and premature rupture of membrane. Zhonghua Yi Xue Za Zhi. 2016; 96(23): 1847–1849.
  22. Namugongo A, Bazira J, Fajardot Y, et al. Group B Streptococcus colonization among pregnant women attending antenatal care at tertiary hospital in rural southwestern uganda. Int J Microbiol. 2016.
  23. Kim EJu, Oh KY, Kim MY, et al. Risk factors for Group B Streptococcus colonization among pregnant women in Korea. Epidemiol Health. 2011; 33: e2011010.
  24. Raabe VN, Shane AL. Group B (). Microbiol Spectr. 2019; 7(2).
  25. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep . 2010; 59(RR-10): 1–36.
  26. Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal Group B Streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016; 9: 351.
  27. Khan MA, Faiz A, Ashshi AM. Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance. Ann Saudi Med. 2015; 35(6): 423–427.
  28. Sands K, Spiller OB, Thomson K, et al. Early-Onset neonatal sepsis in low- and middle-income countries: current challenges and future opportunities. Infect Drug Resist. 2022; 15: 933–946.
  29. Khalil N, Blunt HB, Li Z, et al. Neonatal early onset sepsis in Middle Eastern countries: a systematic review. Arch Dis Child. 2020; 105(7): 639–647.
  30. Topcuoglu S, Demirhan S, Dincer E, et al. Early-Onset neonatal sepsis in Turkey: a single-center 7-year experience in etiology and antibiotic susceptibility. Children (Basel). 2022; 9(11).
  31. Hayes K, O'Halloran F, Cotter L. A review of antibiotic resistance in Group B Streptococcus: the story so far. Crit Rev Microbiol. 2020; 46(3): 253–269.